Pelvidol pregnant is useful in all cases of uterine hypercontractility in pregnancy, threat of abortion, threat of premature birth and after invasive prenatal procedures. It can be taken either alone or in combination with muscle relaxant, pain relieving and anti-inflammatory therapies. It is recommended taking 1 sachet per day for a minimum treatment duration of 4 weeks.
Main causes of uterine hypercontractility in pregnancy:
PEA 300 mg
Magnesium 241,2 mg
Pelvidol pregnant is a food supplement based on Palmitoylethanolamide (PEA) and Magnesium designed to counteract the state of uterine hypercontractility in pregnancy, with specific indication in pathological conditions of threat of abortion and premature birth.
Pelvidol Pregnant contains a high dosage of Magnesium, the supplementation of which helps to counteract neuropsychic disorders (anxiety, anguish, irritability, drop in mood, emotionality, insomnia), neurovegetative somatizations (tachycardia, dyspnoea, extrasystoles, vasoconstriction/ hypertension, pallor, flushing, gastrointestinal symptoms) and neuromuscular manifestations (cramps, paraesthesia, myalgias, physical fatigue, muscular asthenia) and 300 mg of PEA, is a biological modulator that acts as a natural analgesic and anti-inflammatory, very well tolerated and without side effects, in able to decrease the perception of pain and reduce cellular stress. Pelvidol pregnant is indicated for the maintenance of uterine quiescence throughout pregnancy, especially in cases of increased risk of pathological uterine contractile activity, such as multiple pregnancies, conditions of uterine overdistension from polyhydramnios and after invasive prenatal diagnostic procedures. (villocentesis, amniocentesis, cordocentesis).